Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Persistent DNA damage underlies tubular cell polyploidization and progression to chronic kidney disease in kidneys deficient in the DNA repair protein FAN1. | Kidney Int | 2022 | 35931300 | PubTator, text mining | PubMed |
| Transcriptomic effects of propranolol and primidone converge on molecular pathways relevant to essential tremor. | NPJ Genom Med | 2022 | 35927430 | PubTator, text mining | PubMed |
| Coupling to short linear motifs creates versatile PME-1 activities in PP2A holoenzyme demethylation and inhibition. | Elife | 2022 | 35924897 | PubTator, text mining | PubMed |
| MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. | Mol Med | 2022 | 35922756 | PubTator, text mining | PubMed |
| Expression of Long Nonencoding Ribonucleic Acid SNHG20 in Colon Cancer Tissue in Its Influences on Chemotherapeutic Sensitivity of Colon Cancer Cells. | Biomed Res Int | 2022 | 35915794 | PubTator, text mining | PubMed |
| Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence. | Stem Cells Int | 2022 | 35910534 | PubTator, text mining | PubMed |
| Human fibroblasts facilitate the generation of iPSCs-derived mammary-like organoids. | Stem Cell Res Ther | 2022 | 35902878 | PubTator, text mining | PubMed |
| Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma. | Cancers (Basel) | 2022 | 35892846 | PubTator, text mining | PubMed |
| An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer. | Cancers (Basel) | 2022 | 35884419 | PubTator, text mining | PubMed |
| Interleukin-11: A Potential Biomarker and Molecular Therapeutic Target in Non-Small Cell Lung Cancer. | Cells | 2022 | 35883698 | PubTator, text mining | PubMed |
| A Mechanistic Model for Cell Cycle Control in Which CDKs Act as Switches of Disordered Protein Phase Separation. | Cells | 2022 | 35883632 | PubTator, text mining | PubMed |
| CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma. | Mol Cancer | 2022 | 35879762 | PubTator, text mining | PubMed |
| Novel role of COX6c in the regulation of oxidative phosphorylation and diseases. | Cell Death Discov | 2022 | 35879322 | PubTator, text mining | PubMed |
| Replication Stress: A Review of Novel Targets to Enhance Radiosensitivity-From Bench to Clinic. | Front Oncol | 2022 | 35875060 | PubTator, text mining | PubMed |
| The Culture Dish Surface Influences the Phenotype and Dissociation Strategy in Distinct Mouse Macrophage Populations. | Front Immunol | 2022 | 35874686 | PubTator, text mining | PubMed |
| Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma. | Front Genet | 2022 | 35873497 | PubTator, text mining | PubMed |
| Recruitment of a splicing factor to the nuclear lamina for its inactivation. | Commun Biol | 2022 | 35869234 | PubTator, text mining | PubMed |
| Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma. | Nat Commun | 2022 | 35864093 | PubTator, text mining | PubMed |
| N-glycosylation of GDF15 abolishes its inhibitory effect on EGFR in AR inhibitor-resistant prostate cancer cells. | Cell Death Dis | 2022 | 35853851 | PubTator, text mining | PubMed |
| FBXO9 Mediates the Cancer-Promoting Effects of ZNF143 by Degrading FBXW7 and Facilitates Drug Resistance in Hepatocellular Carcinoma. | Front Oncol | 2022 | 35847937 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=27